Used in the pharmaceutical industry as an intermediate in the synthesis of bioactive compounds, particularly those acting on the central nervous system, which may be involved in the treatment of psychiatric disorders or sleep-related conditions, such as anxiety or insomnia. The structure of this compound has potential to bind to receptors in the brain, such as GABA receptors or other receptors involved in modulating neural excitation, and is developed to select as a lead compound for new drugs with high efficacy and low side effects.